Vitae Pharmaceuticals, Inc 5 SEC Filings

Filed On	Filing
15 Jan 2016	Form 5: Hatfield Jeffrey S., Director Granted 50,000 Employee Stock Option (Right to Buy)
15 Jan 2016	Form 5: Fratamico Arthur, Chief Business Officer Granted 13,750 Employee Stock Option (Right to Buy)
15 Jan 2016	Form 5: Morris Richard Steven, Chief Financial Officer Granted 15,000 Employee Stock Option (Right to Buy)
15 Jan 2016	Form 5: Gregg Richard, Chief Scientific Officer Granted 21,250 Employee Stock Option (Right to Buy)

Comments